[1]
R. T. Moraliyska et al., “Effectiveness and safety of upadacitinib – data from real clinical practice in Bulgaria”, Rheumatol Bul, vol. 31, no. 1, pp. 3–16, May 2023, doi: 10.35465/31.1.2023.pp3-16.